CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDER'S DEFICIT (Unaudited) - USD ($)	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Common Stock To Be Issued [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Jun. 30, 2020	$ 181,000	$ 10,000	$ 221,000		$ (351,590)	$ 60,410
Beginning balance, shares at Jun. 30, 2020	181,000,000	10,000,000
Net loss					7,660	7,660
Ending balance, value at Sep. 30, 2020	$ 181,000	$ 10,000	221,000		(343,930)	68,070
Ending balance, shares at Sep. 30, 2020	181,000,000	10,000,000
Net loss					(14,795)	(14,795)
Ending balance, value at Dec. 31, 2020	$ 181,000	$ 10,000	221,000		(358,725)	53,275
Ending balance, shares at Dec. 31, 2020	181,000,000	10,000,000
Stock issued for asset acquisitions	$ 10,000		2,790,000			2,800,000
Stock Issued During Period, Shares, Acquisitions	10,000,000
Net loss					(3,075,916)	(3,075,916)
Ending balance, value at Mar. 31, 2021	$ 191,000	$ 10,000	3,011,000		(3,434,641)	(222,641)
Ending balance, shares at Mar. 31, 2021	191,000,000	10,000,000
Beginning balance, value at Jun. 30, 2021	$ 281,000	$ 10,000	2,921,000		(3,494,730)	(282,730)
Beginning balance, shares at Jun. 30, 2021	281,000,000	10,000,000
Shares issued for conversion of debt	$ 144		29,856	100,000		130,000
Shares issued for conversion of debt, shares	144,231
Options exercised – related party	$ 400		19,600			20,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period	400,000
Fair value of options granted			854,550			854,550
Net loss					(961,262)	(961,262)
Ending balance, value at Sep. 30, 2021	$ 281,544	$ 10,000	3,825,006	100,000	(4,455,992)	(239,442)
Ending balance, shares at Sep. 30, 2021	281,544,231	10,000,000
Beginning balance, value at Jun. 30, 2021	$ 281,000	$ 10,000	2,921,000		(3,494,730)	$ (282,730)
Beginning balance, shares at Jun. 30, 2021	281,000,000	10,000,000
Shares issued for conversion of debt, shares						4,249,961
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period						500,000
Ending balance, value at Mar. 31, 2022	$ 298,448	$ 10,000	4,290,431	3,431	(5,842,443)	$ (1,240,133)
Ending balance, shares at Mar. 31, 2022	298,449,961	10,000,000
Beginning balance, value at Sep. 30, 2021	$ 281,544	$ 10,000	3,825,006	100,000	(4,455,992)	(239,442)
Beginning balance, shares at Sep. 30, 2021	281,544,231	10,000,000
Shares issued for conversion of debt	$ 10,000		90,000	(100,000)
Shares issued for conversion of debt, shares	10,000,000
Options exercised – related party	$ 100		3,943			4,043
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period	100,000
Shares granted for financing costs				3,431		3,431
Net loss					(387,221)	(387,221)
Ending balance, value at Dec. 31, 2021	$ 291,644	$ 10,000	3,918,949	3,431	(4,843,213)	(619,189)
Ending balance, shares at Dec. 31, 2021	291,644,231	10,000,000
Shares issued for conversion of debt	$ 4,104		100,371			104,475
Shares issued for conversion of debt, shares	4,105,730
Shares granted for financing costs	$ 2,700		161,550			164,250
Shares granted for financing costs, shares	2,700,000
Fair value of warrants granted			109,561			109,561
Net loss					(999,230)	(999,230)
Ending balance, value at Mar. 31, 2022	$ 298,448	$ 10,000	$ 4,290,431	$ 3,431	$ (5,842,443)	$ (1,240,133)
Ending balance, shares at Mar. 31, 2022	298,449,961	10,000,000